US Patent Issued to BETH ISRAEL DEACONESS MEDICAL CENTER on May 6 for "Compositions and methods for reducing major thrombotic events in cancer patients" (Massachusetts Inventors)

ALEXANDRIA, Va., June 10 -- United States Patent no. 12,290,527, issued on May 6, was assigned to BETH ISRAEL DEACONESS MEDICAL CENTER INC. (Boston).

"Compositions and methods for reducing major thrombotic events in cancer patients" was invented by Jeffrey I. Zwicker (Boston), Bruce Furie (Boston), Jack Davis Stopa (Boston) and Robert Flaumenhaft (Boston).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to methods for reducing soluble P-selectin and major thrombotic events in cancer patients."

The patent was filed on Jan. 12, 2024, under Application No. 18/412,414.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Pars...